Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Cutaneous Leishmaniasis: Updates in Diagnosis and Management.

Aronson NE, Joya CA.

Infect Dis Clin North Am. 2019 Mar;33(1):101-117. doi: 10.1016/j.idc.2018.10.004. Review.

PMID:
30712756
2.

Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.

Lakhal-Naouar I, Koles N, Rao M, Morrison EB, Childs JM, Alving CR, Aronson NE.

Vaccine. 2019 Jan 14;37(3):516-523. doi: 10.1016/j.vaccine.2018.11.052. Epub 2018 Dec 6.

3.

Asymptomatic Visceral Leishmania infantum Infection in US Soldiers Deployed to Iraq.

Mody RM, Lakhal-Naouar I, Sherwood JE, Koles NL, Shaw D, Bigley DP, Co EA, Copeland NK, Jagodzinski LL, Mukbel RM, Smiley RA, Duncan RC, Kamhawi S, Jeronimo SMB, DeFraites RF, Aronson NE.

Clin Infect Dis. 2019 May 30;68(12):2036-2044. doi: 10.1093/cid/ciy811.

PMID:
30239631
4.

Addressing a clinical challenge: guidelines for the diagnosis and treatment of leishmaniasis.

Aronson NE.

BMC Med. 2017 Apr 7;15(1):76. doi: 10.1186/s12916-017-0843-3.

5.

The Long-term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study.

Mancuso JD, Mody RM, Olsen CH, Harrison LH, Santosham M, Aronson NE.

Chest. 2017 Aug;152(2):282-294. doi: 10.1016/j.chest.2017.01.001. Epub 2017 Jan 10.

PMID:
28087302
6.

The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy.

Lakhal-Naouar I, Slike BM, Aronson NE, Marovich MA.

PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004178. doi: 10.1371/journal.pntd.0004178. eCollection 2015.

7.

Leishmaniasis: treatment updates and clinical practice guidelines review.

Copeland NK, Aronson NE.

Curr Opin Infect Dis. 2015 Oct;28(5):426-37. doi: 10.1097/QCO.0000000000000194. Review.

PMID:
26312442
8.

Leishmania infantum-chagasi activates SHP-1 and reduces NFAT5/TonEBP activity in the mouse kidney inner medulla.

Zhou X, Wang H, Koles NL, Zhang A, Aronson NE.

Am J Physiol Renal Physiol. 2014 Sep 1;307(5):F516-24. doi: 10.1152/ajprenal.00006.2014. Epub 2014 Jul 2. Erratum in: Am J Physiol Renal Physiol. 2014 Oct 15;307(8):F990.

9.

Multidrug-resistant tuberculosis. Recommendations for reducing risk during travel for healthcare and humanitarian work.

Seaworth BJ, Armitige LY, Aronson NE, Hoft DF, Fleenor ME, Gardner AF, Harris DA, Stricof RL, Nardell EA.

Ann Am Thorac Soc. 2014 Mar;11(3):286-95. doi: 10.1513/AnnalsATS.201309-312PS.

PMID:
24673692
10.

Can the active component U.S. military achieve tuberculosis elimination?

Mancuso JD, Aronson NE, Keep LW.

MSMR. 2013 May;20(5):2-3. No abstract available.

PMID:
23731006
11.

Vitamin D deficiency and its association with low bone mineral density, HIV-related factors, hospitalization, and death in a predominantly black HIV-infected cohort.

Sherwood JE, Mesner OC, Weintrob AC, Hadigan CM, Wilkins KJ, Crum-Cianflone NF, Aronson NE.

Clin Infect Dis. 2012 Dec;55(12):1727-36. doi: 10.1093/cid/cis785. Epub 2012 Sep 12.

12.

Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.

Scholler J, Brady TL, Binder-Scholl G, Hwang WT, Plesa G, Hege KM, Vogel AN, Kalos M, Riley JL, Deeks SG, Mitsuyasu RT, Bernstein WB, Aronson NE, Levine BL, Bushman FD, June CH.

Sci Transl Med. 2012 May 2;4(132):132ra53. doi: 10.1126/scitranslmed.3003761.

13.

Discordance among commercially available diagnostics for latent tuberculosis infection.

Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW.

Am J Respir Crit Care Med. 2012 Feb 15;185(4):427-34. doi: 10.1164/rccm.201107-1244OC. Epub 2011 Dec 8.

14.

Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics.

Mancuso JD, Tribble D, Mazurek GH, Li Y, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW.

Clin Infect Dis. 2011 Aug 1;53(3):234-44. doi: 10.1093/cid/cir321.

15.

Health care workers and researchers traveling to developing-world clinical settings: disease transmission risk and mitigation.

Kortepeter MG, Seaworth BJ, Tasker SA, Burgess TH, Coldren RL, Aronson NE.

Clin Infect Dis. 2010 Dec 1;51(11):1298-305. doi: 10.1086/657115. Epub 2010 Nov 1. Review.

PMID:
21039283
16.

A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection.

Aronson NE, Wortmann GW, Byrne WR, Howard RS, Bernstein WB, Marovich MA, Polhemus ME, Yoon IK, Hummer KA, Gasser RA Jr, Oster CN, Benson PM.

PLoS Negl Trop Dis. 2010 Mar 9;4(3):e628. doi: 10.1371/journal.pntd.0000628.

17.

Suspected pulmonary tuberculosis exposure at a remote U.S. Army camp in northeastern Afghanistan, 2007.

Mancuso JD, Aronson NE, Keep LW.

Mil Med. 2008 Dec;173(12):xvii-xviii; author reply xviii. No abstract available.

PMID:
19149329
18.

Positive rK39 serologic assay results in US servicemen with cutaneous leishmaniasis.

Hartzell JD, Aronson NE, Weina PJ, Howard RS, Yadava A, Wortmann GW.

Am J Trop Med Hyg. 2008 Dec;79(6):843-6.

PMID:
19052290
19.

Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004.

Myles O, Wortmann GW, Cummings JF, Barthel RV, Patel S, Crum-Cianflone NF, Negin NS, Weina PJ, Ockenhouse CF, Joyce DJ, Magill AJ, Aronson NE, Gasser RA Jr.

Arch Intern Med. 2007 Sep 24;167(17):1899-901. No abstract available.

PMID:
17893312
20.

In harm's way: infections in deployed American military forces.

Aronson NE, Sanders JW, Moran KA.

Clin Infect Dis. 2006 Oct 15;43(8):1045-51. Epub 2006 Sep 14. Erratum in: Clin Infect Dis. 2006 Dec 1;43(11):1498.

PMID:
16983619
21.

Varicella zoster virus meningitis complicating sodium stibogluconate treatment for cutaneous leishmaniasis.

Hartzell JD, Aronson NE, Nagaraja S, Whitman T, Hawkes CA, Wortmann G.

Am J Trop Med Hyg. 2006 Apr;74(4):591-2.

PMID:
16606989
22.

History of U.S. military contributions to the study of parasitic diseases.

Crum NF, Aronson NE, Lederman ER, Rusnak JM, Cross JH.

Mil Med. 2005 Apr;170(4 Suppl):17-29. Review.

PMID:
15916280
23.

Old world leishmaniasis: an emerging infection among deployed US military and civilian workers.

Weina PJ, Neafie RC, Wortmann G, Polhemus M, Aronson NE.

Clin Infect Dis. 2004 Dec 1;39(11):1674-80. Epub 2004 Nov 9. Review.

PMID:
15578370
24.

Effect of pancreatic and leukocyte elastase on hydraulic conductivity in lung interstitial segments.

Houtz PK, Jones PD, Aronson NE, Richardson LM, Lai-Fook SJ.

J Appl Physiol (1985). 2004 Dec;97(6):2139-47. Epub 2004 Aug 6.

25.

Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons.

Bernstein WB, Cox JH, Aronson NE, Tracy L, Schlienger K, Ratto-Kim S, Garner R, Cotte J, Zheng Z, Winestone L, Liebig C, Galley LM, Connors M, Birx DL, Carroll RG, Levine BL.

Clin Immunol. 2004 Jun;111(3):262-74.

PMID:
15183147
26.

Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study.

Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH.

JAMA. 2004 May 5;291(17):2086-91.

PMID:
15126436
27.

Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial.

Wegner SA, Wallace MR, Aronson NE, Tasker SA, Blazes DL, Tamminga C, Fraser S, Dolan MJ, Stephan KT, Michael NL, Jagodzinski LL, Vahey MT, Gilcrest JL, Tracy L, Milazzo MJ, Murphy DJ, McKenna P, Hertogs K, Rinehart A, Larder B, Birx DL; RV-125 Centers for Education and Research on Therapeutics Study Team.

Clin Infect Dis. 2004 Mar 1;38(5):723-30. Epub 2004 Feb 6.

PMID:
14986258
28.

Effect of concentration and hyaluronidase on restriction of hetastarch flux through lung interstitial segments.

Aronson NE, Houtz PK, Villarruel S, Conhaim RL, Watson KE, Lai-Fook SJ.

Microvasc Res. 2003 Nov;66(3):218-26.

PMID:
14609528
29.

Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort.

Brodine SK, Starkey MJ, Shaffer RA, Ito SI, Tasker SA, Barile AJ, Tamminga CL, Stephan KT, Aronson NE, Fraser SL, Wallace MR, Wegner SA, Mascola JR, McCutchan FE.

AIDS. 2003 Nov 21;17(17):2521-7.

PMID:
14600525
31.

Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen.

Forney JR, Wongsrichanalai C, Magill AJ, Craig LG, Sirichaisinthop J, Bautista CT, Miller RS, Ockenhouse CF, Kester KE, Aronson NE, Andersen EM, Quino-Ascurra HA, Vidal C, Moran KA, Murray CK, DeWitt CC, Heppner DG, Kain KC, Ballou WR, Gasser RA Jr.

J Clin Microbiol. 2003 Jun;41(6):2358-66.

32.

Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

Levine BL, Bernstein WB, Aronson NE, Schlienger K, Cotte J, Perfetto S, Humphries MJ, Ratto-Kim S, Birx DL, Steffens C, Landay A, Carroll RG, June CH.

Nat Med. 2002 Jan;8(1):47-53.

PMID:
11786906
33.

Selective serotonin reuptake inhibitors and isoniazid: evidence of a potential adverse interaction.

Doyle ME, Hicks D, Aronson NE.

Mil Med. 2001 Dec;166(12):1054-6.

PMID:
11778402
34.

Biliary giardiasis in a patient with human immunodeficiency virus.

Aronson NE, Cheney C, Rholl V, Burris D, Hadro N.

J Clin Gastroenterol. 2001 Aug;33(2):167-70.

PMID:
11468450
35.

Inferior vena cava compression due to massive hydronephrosis from bladder outlet obstruction.

Davis GC, Aronson NE, Moul JW.

Tech Urol. 2000 Sep;6(3):226-7.

PMID:
10963496
36.

Cutaneous leishmaniasis following local trauma: a clinical pearl.

Wortmann GW, Aronson NE, Miller RS, Blazes D, Oster CN.

Clin Infect Dis. 2000 Jul;31(1):199-201. Review.

PMID:
10913426
37.

Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine.

Cox JH, Garner RP, Redfield RR, Aronson NE, Davis C, Ruiz N, Birx DL.

AIDS Res Hum Retroviruses. 1999 Jun 10;15(9):847-54.

PMID:
10381173
38.

Immunohistochemistry to identify Leishmania parasites in fixed tissues.

Kenner JR, Aronson NE, Bratthauer GL, Turnicky RP, Jackson JE, Tang DB, Sau P.

J Cutan Pathol. 1999 Mar;26(3):130-6.

PMID:
10235378
39.

The United States military and leishmaniasis.

Kenner JR, Aronson NE, Benson PM.

Dermatol Clin. 1999 Jan;17(1):77-92, viii. Review.

PMID:
9986997
40.

Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience.

Aronson NE, Wortmann GW, Johnson SC, Jackson JE, Gasser RA Jr, Magill AJ, Endy TP, Coyne PE, Grogl M, Benson PM, Beard JS, Tally JD, Gambel JM, Kreutzer RD, Oster CN.

Clin Infect Dis. 1998 Dec;27(6):1457-64.

PMID:
9868660
41.

Persistent nephrolithiasis after discontinuation of indinavir therapy.

Polhemus ME, Aronson NE.

Clin Infect Dis. 1998 Dec;27(6):1536-7. No abstract available.

PMID:
9868678
42.

Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis.

Wortmann GW, Aronson NE, Byrd JC, Grever MR, Oster CN.

Clin Infect Dis. 1998 Sep;27(3):509-12.

PMID:
9770149
43.

Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis.

Wortmann GW, Fraser SL, Aronson NE, Davis C, Miller RS, Jackson JD, Oster CN.

Clin Infect Dis. 1998 Apr;26(4):1006-7. No abstract available.

PMID:
9564500
44.

Recurrent Helicobacter cinaedi bacteremia in a patient infected with human immunodeficiency virus: case report.

Mammen MP Jr, Aronson NE, Edenfield WJ, Endy TP.

Clin Infect Dis. 1995 Oct;21(4):1055. No abstract available.

PMID:
8645814
45.

Lytic vertebral lesions: an unusual manifestation of AIDS-associated Kaposi's sarcoma.

Isenbarger DW, Aronson NE.

Clin Infect Dis. 1994 Oct;19(4):751-5. Review.

PMID:
7803643
46.

Systemic sporotrichosis treated with itraconazole.

Winn RE, Anderson J, Piper J, Aronson NE, Pluss J.

Clin Infect Dis. 1993 Aug;17(2):210-7.

PMID:
8399869
47.

Posterior subcapsular cataracts associated with megestrol acetate therapy.

Aronson NE, Amegin GP.

J Cataract Refract Surg. 1993 Jan;19(1):90-1.

PMID:
8426332
48.

Disseminated sporotrichosis.

Aronson NE.

JAMA. 1992 Oct 21;268(15):2021. No abstract available.

PMID:
1404730
49.

Predictors of HIV-1 disease progression in early- and late-stage patients: the U.S. Army Natural History Cohort. Military Medical Consortium for Applied Retrovirology.

Gardner LI Jr, Brundage JF, McNeil JG, Milazzo MJ, Redfield RR, Aronson NE, Craig DB, Davis C, Gates RH, Levin LI, et al.

J Acquir Immune Defic Syndr. 1992;5(8):782-93.

PMID:
1517964
50.

Immunization of owl monkeys with a recombinant protein containing repeated epitopes of a Plasmodium falciparum glycophorin-binding protein.

Aronson NE, Silverman C, Wasserman GF, Kochan J, Hall BT, Esser K, Young JE, Chulay JD.

Am J Trop Med Hyg. 1991 Nov;45(5):548-59.

PMID:
1719834

Supplemental Content

Loading ...
Support Center